Filing Details

Accession Number:
0001104659-19-041307
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-22 16:32:02
Reporting Period:
2019-07-22
Accepted Time:
2019-07-22 16:32:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680581 Fulcrum Therapeutics Inc. FULC Pharmaceutical Preparations (2834) 474839948
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1717958 6 Dimensions Capital, L.p. Po Box 309, Ugland House
Grand Cayman, Cayman Islands KY 1-1104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-22 441,071 $0.00 441,071 No 4 C Direct
Common Stock Acquisiton 2019-07-22 118,750 $16.00 559,821 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2019-07-22 3,087,500 $0.00 441,071 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date.